Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Kansas City, MO
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Fargo, ND
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Birmingham, AL
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Scottsdale, AZ
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Tucson, AZ
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Duarte, CA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Duarte, CA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Fountain Valley, CA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
La Jolla, CA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
New Haven, CT
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Hollywood, FL
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Tampa, FL
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
West Palm Beach, FL
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Marietta, GA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Thomasville, GA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Thomasville, GA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Chicago, IL
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Quincy, IL
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Quincy, IL
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Evansville, IN
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
New Albany, IN
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
New Albany, IN
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Westwood, KA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Westwood, KA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Wichita, KA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Louisville, KY
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Columbia, MD
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Columbia, MD
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Fairhaven, MA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Fairhaven, MA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
St Louis, MO
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Bronx, NY
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
New York, NY
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Charleston, SC
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Memphis, TN
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Nashville, TN
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Bedford, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Dallas, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Longview, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Longview, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Odessa, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Odessa, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
San Marcos, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
San Marcos, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Sherman, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Sherman, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Sugar Land, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
The Woodlands, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Wichita Falls, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Burlington, VT
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Spokane, WA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Vancouver, WA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Vancouver, WA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Morgantown, WV
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Madison, WI
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
mi
from
Buenos Aires,
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
mi
from
Buenos Aires,
Click here to add this to my saved trials
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated:  10/23/2015
Providence Cancer Center
mi
from
Anchorage, AK
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated: 10/23/2015
Providence Cancer Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated:  10/23/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
mi
from
Tucson, AZ
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated: 10/23/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated:  10/23/2015
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
mi
from
Ft. Smith, AR
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated: 10/23/2015
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
mi
from
Ft. Smith, AR
Click here to add this to my saved trials